Ⅲ期临床屡受挫、尚未有新药上市,开拓药业瞄准化妆品赛道

新京报
15 Mar

开拓药业近日宣布,就化妆品业务海外市场的相关业务签订运营合作协议。作为创新药研发企业,开拓药业在上市5年间,多次遭遇Ⅲ期临床失败,亏损超34亿元,如今却以化妆品实现了首款产品商业化。2024年上半年研发费用、行政开支均大幅缩减,“节衣缩食”的开拓药业能否靠化妆品业务翻身?  押注化妆品赛道  3月12日,开拓药业宣布,其全资附属公司苏州开拓药业股份有限公司(简称“苏州开拓”)与杭州涂麦科技有限公司...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10